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Purpose/Objective: The determination of beam width for 
selected energy and focus combinations is frequently 
performed at the Heidelberg Ion-Beam Therapy Center (HIT). 
For beam width adjustment a scintillating screen detector 
(SD, in-house production) is used and radiographic film is 
employed for the subsequent quality assurance. As the width 
measurement results of these detectors show deviations, an 
iterative beam adjustment process is used. To improve and 
speed up this process and to replace the irradiation- and 
evaluation-time-intensive film measurements, a comparison 
of 5 different detectors is currently performed. 
Materials and Methods: Vertically scanned carbon ion line 
fields with a beam width of 6-10mm were used to compare 
lateral beam width results from radiographic Xomat V film 
(Kodak), a SD, a flatpanel detector (FPD, XRD 0822 without 
scintillator, PerkinElmer) and a multiwire chamber (MW, 
MWPC Type I, Siemens) against those from a linear array of 
12 pinpoint ionization chambers (IC, TM31015, PTW) as the 
gold standard in absolute dosimetry. For the first 3 detectors 
background corrected .tiff images containing the 
accumulated measurement of the whole scanned irradiation 
field were used as the result. As the MW integrates over 
time-increments of 400 µs, the beam width was calculated 
for each of these time-increments and the final result 
subsequently averaged over all single measurements. For the 
IC results, serving as the reference, the array was shifted in 
2mm steps perpendicular to the scanned field and the 
irradiation repeated for each array position. For all 
detectors, the lateral beam width was obtained as the FWHM 
value and complementary calculated from a single Gaussian 
fit. 
Results: The comparison of the beam width measured with 
different detectors compared to IC measurements resulted in 
the maximum deviations presented in Tab. 1. 
 
 
 
Tab. 1: Comparison of the beam width measured with 
different detectors compared to measurements with a linear 
IC array. 
 
Conclusions: The beam width results from 4 detectors 
compared to IC measurements show good agreement below 
0.5mm for FWHM values obtained from SD and FPD 
measurements. With film and MW, larger deviations from the 
IC results were observed and need to be further investigated. 
A comparison of the results also shows that SD and FD 
measure a beam width larger than the IC, while the beam 
widths obtained with film and MW are smaller. Currently, 
results from line and single spot fields are compared and the 
beam width evaluation is further optimized.  
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Purpose/Objective: The purpose of this study was to 
independently verify the manufacturer’s stated CAX dose-
rate from a Ru-106 eye plaque. Due to the small dimensions 
and curvature of Ru-106 plaques, the determination of the 
dosimetric characteristics represents a technical challenge 
with relatively large uncertainties. This makes it difficult for 
an institution to implement a robust system to verify a 
plaques dose-rate before it is used clinically. Previous studies 
have investigated the PTW Diamond detector and different 
versions of Radiochromic film for beta plaque dosimetry. Two 
relatively new additions to the market, the PTW 
Microdiamond detector and EBT3 film have yet to be 
evaluated.  
Materials and Methods: EBT3 films were inserted between 
1mm sheets of Plastic Water® cut to different sized 
concentric circles in order to fit within the plaque’s concave 
face for 90 minutes. Each film yielded the dose-rate at 
regular intervals perpendicular to the plaque surface. The 
PTW Microdiamond detector was mounted vertically in a 
water tank, suspended by Vernier callipers which were 
modified to allow the precise vertical movement of the 
detector along the plaques CAX. Each distance measurement 
was undertaken for 120 seconds to obtain a reasonable signal 
up to 1cm from the plaque surface. The results were 
compared to the PTW Diamond detector results obtained 
using the same configuration. 
Results: The reference dose rate measured independently 
using EBT3 film in this work was found to agree with the 
manufacturer’s calibration certificate dose rate to within 
1.5% +/- 16%. The PTW Diamond and Microdiamond measured 
reference dose rates agreed the calibration certificate dose 
rate within 8.3% +/- 14.4% and 48.8% +/- 14.6% respectively. 
The uncertainties were comparable to the manufacturer’s 
calibration uncertainty of +/-20%. 
Conclusions: This study found that EBT3 film and the PTW 
Diamond detector are effective tools in validating the 
manufacturers stated dose rates. The results of both 
detectors lie within the manufacturer’s calibration 
certificate uncertainty of +/-20%. However, the new PTW 
Microdiamond yielded a consistently higher reference dose 
rate (>48%) when compared to the EBT3 film and PTW 
Diamond detector. The authors propose the difference is due 
to the energy dependence attributed to the difference in 
construction materials, elucidated using a Micro-CT system, 
between the two detectors. In addition, a PTW SourceCheck 
air ionisation chamber was evaluated as a consistency check 
tool to verify the Ru-106 plaque dose rate on a routine basis. 
Placing a Ru-106 plaque in the centre of the PTW 
S742                                                                                                                                         3rd ESTRO Forum 2015 
 
SourceCheck detector yielded consistent results within 1% 
when a rotation of 180o or positional error of up to 0.5cm was 
introduced in any direction. Using a PTW SourceCheck, 
calibrated for each plaque type using EBT3 film (or the PTW 
diamond detector) may offer an efficient and robust method 
for routinely verifying Ru-106 plaques.  
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Purpose/Objective: Intra Operative Radiation Therapy (IORT) 
is a treatment modality which delivers a large single 
radiation dose (about 8-23Gy) during a surgery procedure. 
Accelerators specifically designed for IORT are characterized 
by outputs rate (about 3–12cGy/pulse) several times higher 
than conventional accelerators (0.1–0.6cGy/pulse). Because a 
very high dose values in a single fraction is delivered, a check 
between the planned dose and the delivered dose is 
mandatory by using in vivo dosimetry. Thermoluminescent 
dosimeters (TLDs) are widely used for in vivo dosimetry on 
patients during conventional radiotherapy treatment. Aim of 
the present study is to evaluate the potential of TLDs as in 
vivo dosimeters during an IORT treatment. The 
characterization of TLDs' response to a 6 MV low dose-per-
pulse photon beam from a conventional clinic linear 
accelerator as well as to a 9 MeV high dose-per-pulse 
electron beams from an IORT device, in the range 0-10Gy, 
was carried out. 
Materials and Methods: The TLDs used were LiF:Mg,Ti (TLD-
100, Harshaw Chemical Company) chips. TLDs were irradiated 
with a 6MV photon beam in an equivalent water phantom in 
reference conditions (100 cm from the source, depth of 5 cm, 
beam size of 10x10 cm2). The readout of TLDs was performed 
by a Harshaw model 3500 manual TLD reader, at 300 °C using 
a heating rate of 10 °C/s. After being processed, TLDs were 
irradiated with a 9 MeV IORT electron beam at the deep of 
the maximum dose (13 mm). The distance between the 
source and the upper surface of the phantom was of 100 cm 
and the field diameter was 10 cm. With both energies, the 
TLDs were divided into five groups of eight TLDs and 
irradiated from 2 to 10 Gy in step of 2 Gy. For all the beams 
a linear and a quadratic regression was performed between 
TLD response and doses delivered. The goodness of the fit 
was evaluated by the R2 coefficient. The better performance 
of the two models was assessed by F test.  
Results: The TLDs' response at a 6MV photon beam and 9MeV 
electron beam was reported in Figure 1a-1b. The results show 
very close R2 values for the linear and the quadratic models 
(Table 1). The F test approved the linear model as the better 
model (p=0,169) for the photon beam, while it approved the 
quadratic model (p<0.0004) for the electron beam. 
 
 
 
 
Conclusions: In this work, we investigated the response of 
LiF:Mg,Ti (TLD-100) when irradiated by a 6 MV photon beam 
and for the first time by a 9MeV electron beam in the range 
0-10 Gy. The results confirm the linear behaviour of TLD-100 
irradiated by a conventional photon beam in this range of 
doses. Furthermore, they suggest that the response of TLD-
100 irradiate by a high dose per pulse rate electron beams is 
better described by a quadratic function of the absorbed 
dose. We suggest the use of TLD-100 for in vivo dosimetry, in 
the range 0-10 Gy, also in an IORT surgery, in which a high 
dose per pulse beam is used, taking into account the 
quadratic behaviour of the response of TLDs to the absorbed 
dose. 
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Purpose/Objective: The objective of this work is to report on 
the development of a general-purpose tool kit that can be 
used for dosimetric commissioning of new treatment 
modalities in radiotherapy. Alanine measurements in 
anthropomorphic phantoms are used for establishing 
traceability to a primary standard and fiber-coupled 
luminescence dosimetry with small inorganic crystals or 
organic plastic scintillators are used for time-resolved 
measurements in phantoms or in vivo. We demonstrate and 
discuss the use of the tool kit on the basis of a phantom-
based commissioning of a new procedure for total body 
irradiation (TBI).  
Materials and Methods: The studied TBI involved a 
combination of multileaf collimator defined fields and wide-
open diamond fields of 6 MV x-ray beams delivered at 350 cm 
SSD. A PMMA spoiler in front of the patient minimized the 
build-up region in the patient. No cerrobend lung blocks were 
used. The treatment planning was performed using Eclipse v. 
11 (Varian Medical Systems, USA). About 2 Gy were delivered 
per fraction. Fiber-coupled dosimetry was based on 
